Stoxx Europe 50
|
4 967,21
|
-10,51
|
-0,21 %
|
Analysen zu Stoxx Europe 50-Werten
| 05.02.25 | Allianz Buy | Deutsche Bank AG | |
| 05.02.25 | TotalEnergies Buy | UBS AG | |
| 05.02.25 | L'Oréal Underweight | JP Morgan Chase & Co. | |
| 05.02.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Buy | UBS AG | |
| 05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Santander Buy | UBS AG | |
| 05.02.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.02.25 | Unilever Outperform | Bernstein Research | |
| 05.02.25 | L'Oréal Market-Perform | Bernstein Research | |
| 05.02.25 | Nestlé Market-Perform | Bernstein Research | |
| 05.02.25 | Santander Neutral | JP Morgan Chase & Co. | |
| 05.02.25 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | BNP Paribas Neutral | UBS AG | |
| 04.02.25 | Iberdrola Sector Perform | RBC Capital Markets | |
| 04.02.25 | BBVA Outperform | RBC Capital Markets | |
| 04.02.25 | BNP Paribas Outperform | RBC Capital Markets | |
| 04.02.25 | L'Oréal Neutral | UBS AG | |
| 04.02.25 | Iberdrola Neutral | JP Morgan Chase & Co. | |
| 04.02.25 | Intesa Sanpaolo Buy | UBS AG | |
| 04.02.25 | Intesa Sanpaolo Buy | Jefferies & Company Inc. | |
| 04.02.25 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
| 04.02.25 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.02.25 | BNP Paribas Outperform | RBC Capital Markets | |
| 04.02.25 | Roche Sell | Deutsche Bank AG | |
| 04.02.25 | BNP Paribas Neutral | UBS AG | |
| 04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 04.02.25 | BNP Paribas Buy | Goldman Sachs Group Inc. | |
| 04.02.25 | SAP Add | Baader Bank | |
| 04.02.25 | UBS Hold | Deutsche Bank AG | |
| 04.02.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 04.02.25 | BNP Paribas Neutral | JP Morgan Chase & Co. | |
| 04.02.25 | Novartis Buy | Deutsche Bank AG | |
| 04.02.25 | UBS Outperform | RBC Capital Markets | |
| 04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 03.02.25 | Novo Nordisk Buy | UBS AG | |
| 03.02.25 | AB InBev Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | Roche Underweight | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
| Unilever | 9 |
| AstraZeneca | 5 |
| BP | 4 |
| VINCI | 3 |
| Shell | 3 |
| TotalEnergies | 3 |
| EssilorLuxottica | 3 |
| GSK | 2 |
| Novo Nordisk | 2 |
| London Stock Exchange | 2 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.